RecruitingNCT00260559

Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life


Sponsor

University of Pittsburgh

Enrollment

3,500 participants

Start Date

May 1, 1999

Study Type

OBSERVATIONAL

Conditions

Summary

To assess short and long term outcomes after minimally invasive esophagectomy compared to open esophagectomy. To compare both standard outcome measures as well as patient derived outcome measures, in particular, quality of life (QOL). To look at the applicability of this QOL instrument to this patient group.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following patients who undergo surgery to remove the esophagus (esophagectomy) — either using minimally invasive techniques or traditional open surgery — to compare outcomes and quality of life. **You may be eligible if...** - You are scheduled to have minimally invasive esophagectomy (MIE) - You are scheduled to have traditional open esophagectomy - You are 18 years of age or older - You have signed an informed consent form **You may NOT be eligible if...** - You are unable to understand or complete the quality-of-life questionnaires - You are under 18 years of age Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREQuestionnaires

Quality of life and heartburn assessment questionnaires are administered preoperatively and at set intervals postoperatively.


Locations(2)

University of Pittsburgh Medical Center - Department of Cardiothoracic Surgery

Pittsburgh, Pennsylvania, United States

UPMC - Hillman Cancer Center

Pittsburgh, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00260559


Related Trials